基于国民健康保险服务数据库的韩国老年人永久性血管通路的结果评估

IF 1.2 4区 医学 Q3 UROLOGY & NEPHROLOGY Hemodialysis International Pub Date : 2023-03-21 DOI:10.1111/hdi.13077
Hyangkyoung Kim, Hoon Suk Park, Tae Hyun Ban, Seung Boo Yang, Young joo Kwon, the vascular access working group of the Korean Society of Dialysis Access
{"title":"基于国民健康保险服务数据库的韩国老年人永久性血管通路的结果评估","authors":"Hyangkyoung Kim,&nbsp;Hoon Suk Park,&nbsp;Tae Hyun Ban,&nbsp;Seung Boo Yang,&nbsp;Young joo Kwon,&nbsp;the vascular access working group of the Korean Society of Dialysis Access","doi":"10.1111/hdi.13077","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Introduction</h3>\n \n <p>As nearly half of patients with end-stage kidney disease (ESKD) who initiate hemodialysis (HD) are over 65 years old (commonly defined as elderly), the fistula first strategy is controversial even in HD patients ≥65 years.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>In Korea's National Health Insurance Service database from 2008 to 2019, 41,989 elderly (≥ 65 years) HD patients were retrospectively reviewed to identify their clinical characteristics and outcomes. Vascular access (VA) patencies, risk factors associated with patencies and patient survival between arteriovenous fistula (AVF) and arteriovenous graft (AVG) were compared.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Elderly AVF group (n = 28,467) had superior primary, primary assisted, and secondary patencies than elderly AVG group (n = 13,522) (all <i>p</i> values are &lt;0.001). Patient survival was also better in the elderly AVF group than in the elderly AVG (<i>p</i> &lt; 0.001). In multivariate Cox regression analyses for diverse outcomes, AVG (vs. AVF) was identified as a risk factor for all-cause mortality (adjusted hazard ratio [HR]: 1.307; 95% confidence interval [CI]: 1.272–1.343; <i>p</i> &lt; 0.001), primary patency (adjusted HR: 1.745; 95% CI: 1.701–1.790; <i>p</i> &lt; 0.001), primary-assisted patency (adjusted HR: 2.163; 95% CI: 2.095–2.233; <i>p</i> &lt; 0.001), and secondary patency (adjusted HR: 3.718; 95% CI: 3.533–3.913; <i>p</i> &lt; 0.001).</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Our study demonstrated that as a permanent VA for HD, AVF should be strongly considered in elderly (≥ 65 years) ESKD Korean patients. The age limit for AVF creation in ESKD patients should be adjusted more upward.</p>\n </section>\n </div>","PeriodicalId":12815,"journal":{"name":"Hemodialysis International","volume":null,"pages":null},"PeriodicalIF":1.2000,"publicationDate":"2023-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Evaluation of outcomes with permanent vascular access in an elderly Korean population based on the National Health Insurance Service database\",\"authors\":\"Hyangkyoung Kim,&nbsp;Hoon Suk Park,&nbsp;Tae Hyun Ban,&nbsp;Seung Boo Yang,&nbsp;Young joo Kwon,&nbsp;the vascular access working group of the Korean Society of Dialysis Access\",\"doi\":\"10.1111/hdi.13077\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div>\\n \\n \\n <section>\\n \\n <h3> Introduction</h3>\\n \\n <p>As nearly half of patients with end-stage kidney disease (ESKD) who initiate hemodialysis (HD) are over 65 years old (commonly defined as elderly), the fistula first strategy is controversial even in HD patients ≥65 years.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Methods</h3>\\n \\n <p>In Korea's National Health Insurance Service database from 2008 to 2019, 41,989 elderly (≥ 65 years) HD patients were retrospectively reviewed to identify their clinical characteristics and outcomes. Vascular access (VA) patencies, risk factors associated with patencies and patient survival between arteriovenous fistula (AVF) and arteriovenous graft (AVG) were compared.</p>\\n </section>\\n \\n <section>\\n \\n <h3> Results</h3>\\n \\n <p>Elderly AVF group (n = 28,467) had superior primary, primary assisted, and secondary patencies than elderly AVG group (n = 13,522) (all <i>p</i> values are &lt;0.001). Patient survival was also better in the elderly AVF group than in the elderly AVG (<i>p</i> &lt; 0.001). In multivariate Cox regression analyses for diverse outcomes, AVG (vs. AVF) was identified as a risk factor for all-cause mortality (adjusted hazard ratio [HR]: 1.307; 95% confidence interval [CI]: 1.272–1.343; <i>p</i> &lt; 0.001), primary patency (adjusted HR: 1.745; 95% CI: 1.701–1.790; <i>p</i> &lt; 0.001), primary-assisted patency (adjusted HR: 2.163; 95% CI: 2.095–2.233; <i>p</i> &lt; 0.001), and secondary patency (adjusted HR: 3.718; 95% CI: 3.533–3.913; <i>p</i> &lt; 0.001).</p>\\n </section>\\n \\n <section>\\n \\n <h3> Conclusion</h3>\\n \\n <p>Our study demonstrated that as a permanent VA for HD, AVF should be strongly considered in elderly (≥ 65 years) ESKD Korean patients. The age limit for AVF creation in ESKD patients should be adjusted more upward.</p>\\n </section>\\n </div>\",\"PeriodicalId\":12815,\"journal\":{\"name\":\"Hemodialysis International\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2023-03-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hemodialysis International\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/hdi.13077\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hemodialysis International","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/hdi.13077","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

由于近一半开始进行血液透析(HD)的终末期肾病(ESKD)患者年龄超过65岁(通常定义为老年人),因此即使在≥65岁的HD患者中,瘘管优先策略也存在争议。方法对2008年至2019年韩国国民健康保险服务数据库中41989例老年(≥65岁)HD患者进行回顾性分析,以确定其临床特征和结局。比较动静脉瘘(AVF)和动静脉移植物(AVG)的血管通路(VA)通畅度、相关危险因素及患者生存率。结果老年AVF组(n = 28,467)的原发性、原发性辅助和继发性通畅率均高于老年AVG组(n = 13,522) (p值均为<0.001)。老年AVF组患者生存率也高于老年AVG组(p < 0.001)。在多种结局的多变量Cox回归分析中,AVG (vs. AVF)被确定为全因死亡的危险因素(校正危险比[HR]: 1.307;95%置信区间[CI]: 1.272-1.343;p < 0.001),原发性通畅(调整后HR: 1.745;95% ci: 1.701-1.790;p < 0.001),原发性辅助通畅(调整后风险比:2.163;95% ci: 2.095-2.233;p < 0.001)和继发性通畅(调整后HR: 3.718;95% ci: 3.533-3.913;p < 0.001)。结论:我们的研究表明,对于老年(≥65岁)韩国ESKD患者,应强烈考虑AVF作为HD的永久性VA。ESKD患者产生AVF的年龄限制应该向上调整。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Evaluation of outcomes with permanent vascular access in an elderly Korean population based on the National Health Insurance Service database

Introduction

As nearly half of patients with end-stage kidney disease (ESKD) who initiate hemodialysis (HD) are over 65 years old (commonly defined as elderly), the fistula first strategy is controversial even in HD patients ≥65 years.

Methods

In Korea's National Health Insurance Service database from 2008 to 2019, 41,989 elderly (≥ 65 years) HD patients were retrospectively reviewed to identify their clinical characteristics and outcomes. Vascular access (VA) patencies, risk factors associated with patencies and patient survival between arteriovenous fistula (AVF) and arteriovenous graft (AVG) were compared.

Results

Elderly AVF group (n = 28,467) had superior primary, primary assisted, and secondary patencies than elderly AVG group (n = 13,522) (all p values are <0.001). Patient survival was also better in the elderly AVF group than in the elderly AVG (p < 0.001). In multivariate Cox regression analyses for diverse outcomes, AVG (vs. AVF) was identified as a risk factor for all-cause mortality (adjusted hazard ratio [HR]: 1.307; 95% confidence interval [CI]: 1.272–1.343; p < 0.001), primary patency (adjusted HR: 1.745; 95% CI: 1.701–1.790; p < 0.001), primary-assisted patency (adjusted HR: 2.163; 95% CI: 2.095–2.233; p < 0.001), and secondary patency (adjusted HR: 3.718; 95% CI: 3.533–3.913; p < 0.001).

Conclusion

Our study demonstrated that as a permanent VA for HD, AVF should be strongly considered in elderly (≥ 65 years) ESKD Korean patients. The age limit for AVF creation in ESKD patients should be adjusted more upward.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Hemodialysis International
Hemodialysis International UROLOGY & NEPHROLOGY-
CiteScore
2.50
自引率
0.00%
发文量
58
审稿时长
6-12 weeks
期刊介绍: Hemodialysis International was originally an annual publication containing the Proceedings of the International Symposium on Hemodialysis held in conjunction with the Annual Dialysis Conference. Since 2003, Hemodialysis International is published quarterly and contains original papers on clinical and experimental topics related to dialysis in addition to the Annual Dialysis Conference supplement. This journal is a must-have for nephrologists, nurses, and technicians worldwide. Quarterly issues of Hemodialysis International are included with your membership to the International Society for Hemodialysis. The journal contains original articles, review articles, and commentary to keep readers completely updated in the field of hemodialysis. Edited by international and multidisciplinary experts, Hemodialysis International disseminates critical information in the field.
期刊最新文献
Issue Information Impact of specialized renal technologists on optimizing delivery of continuous kidney replacement therapy in critical care areas a retrospective study Metal phosphide poisoning in a disaster-stricken area. Can early hemodialysis improve outcomes? The effect of implementing a dialysis start unit on modality decision among patients with unplanned start kidney replacement therapy Effects of a medium cut-off dialyzer on inflammation and cardiac and vascular function in hemodialysis patients with heart failure
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1